DOCSLIB.ORG

Consultant Cardiologist with an Interest in Interventional Cardiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Consultant Cardiologist with an Interest in Interventional Cardiology CONSULTANT CARDIOLOGIST WITH AN INTEREST IN INTERVENTIONAL CARDIOLOGY Contents Page 1 The Post 2 2 Royal Papworth Hospital 3 3 The Cardiology Directorate 4 4 Intensive Care Unit 6 5 Transplantation & Mechanical Circulatory Support 6 6 Cardiothoracic Surgery 7 7 Thoracic Medicine 7 8 Research, Development and Audit 7 9 Postgraduate Education 8 10 Duties of the Post 8 - Draft Job Plan 9 11 Terms and conditions 9 12 Brief Terms of Appointment 10 13 General Information 13 14 Informal Visits 13 Person Specification 13 Consultant interventional substantive post Oct 2019 1/13 CONSULTANT CARDIOLOGIST WITH INTEREST IN INTERVENTIONAL CARDIOLOGY 1 The Post This is a full-time substantive NHS Consultant post to support the interventional cardiology service at Royal Papworth Hospital. Royal Papworth Hospital NHS Foundation Trust is seeking a Consultant Cardiologist in Interventional Cardiology. The post-holder will have appropriate experience and expertise in coronary intervention. An interest in an additional sub-speciality (e.g. structural intervention) would be welcome. The post-holder will be appointed to the Cardiology Directorate at Royal Papworth Hospital. The interventional cardiology service currently provides PCI to around 2200 patients per annum (including 700 PPCI) and 180 TAVI per annum. The TAVI service, which has been provided at Royal Papworth Hospital for over 10 years, continues to grow rapidly and is projected to provide TAVI for 200+ patients per annum by 2020. Other structural interventional procedures are also performed at Royal Papworth (e.g. PFO/ASD closure, LAA closure, paravalvular leak closure, balloon pulmonary angioplasty) and a programme of percutaneous mitral valve treatment is under development. This new full-time post will join the existing team of 11 interventional consultants (including 4 TAVI operators) to provide interventional cardiology services, while supporting education and research as part of Royal Papworth Hospitals’ Tripartite Mission. The appointee will take on the responsibility of supporting the coronary intervention service and will have the opportunity to participate in the structural intervention service if suitably experienced. The post-holder will also be a member of the Interventional Consultant of the Week rota and participate in the out of hours on-call service. The Job Plan is for 10 PA’s with a 1 in 12 PPCI on-call commitment with the possibility to negotiate additional PA’s. The new consultant will be mentored and supported by the existing interventional cardiologists and will also have a named mentor outside of the immediate working environment. The post-holder will be expected to deliver a high quality service and implement Trust guidelines throughout the scope of their practice. The post-holder will have office space, personal computer access with support from the IT Department, and secretarial support. Key Responsibilities 1. Contribute to interventional cardiology services including ward cover, chest pain clinics, diagnostic angiography, elective angioplasty, “hot lab” sessions and admission of patients through the Primary PCI (PPCI) and rapid NSTEMI pathways. The post holder will also form part of the PPCI out of hours service after a period of buddying. 2. Managing acute coronary syndrome including urgent referral for coronary surgery and involvement in the heart team multidisciplinary team meetings. 3. Contribute to the training of junior doctors in accordance with standards required by College, Postgraduate Dean and Trust. Participate in the training, supervision and development of specialist heart nurses. Participate in the education programme for medical students attached to Papworth. 4. Demonstrate a commitment to continuing professional development. 5. Work with the team to support the research programme, and to contribute to audit Consultant interventional substantive post Oct 2019 2/13 activities. 2 Royal Papworth Hospital Royal Papworth Hospital is at the centre of a regional and national network of hospitals caring for patients with heart and lung disease. From a tuberculosis hospital when it opened in 1917, Papworth Hospital has developed into an internationally recognised heart and lung centre and is the leading cardiothoracic specialist hospital in the United Kingdom. Royal Papworth Hospital relocated to the Cambridge Biomedical Campus in May 2019, providing unprecedented opportunities for collaboration with Cambridge University Hospitals Foundation Trust and collocated research institutions and biomedical and pharmaceutical companies. http://www.royalpapworthhospital.nhs.uk/nph/ Royal Papworth Hospital currently treats around 24,400 inpatients and day patients and sees over 73,600 outpatients per year. It has over 1,800 staff, 289 beds and an annual budget of over £110 million. We are recognised as: a high achieving hospital, with excellent external reviews; the regional heart attack centre; the regional TAVI service; the regional ASD / PFO service; the regional specialist valve and structural heart service; the regional HOCM assessment and intervention service a designated National Pulmonary Hypertension Centre (PVDU); being one of 5 designated centres for Respiratory ECMO; the largest cardiac surgical unit in the UK; one of the UK’s largest heart and lung transplant centres and one of the UK’s 3 designated centres for ventricular assist devices having the largest mitral valve surgery programme in the United Kingdom the only designated UK centre for pulmonary endarterectomy and balloon pulmonary angioplasty We have a reputation for being one of the best performing hospitals in the country, a status that we are determined to maintain. There is a pioneering spirit throughout and a culture of embracing new ideas in all aspects of healthcare, but with meticulous monitoring and review of clinical outcomes both in established and novel treatment modalities. In achieving this position, we have established a reputation for innovative clinical developments. These have been underpinned by substantial research, development and education. Royal Papworth Hospital was one of the first 20 hospitals in England to be granted NHS Foundation Trust status in 2004. A full summary of the key clinical milestones and the capital program since 1995 can be seen on the hospitals website. http://www.papworthhospital.nhs.uk/index.php Management and Staff Papworth hospital has 5 clinical directorates that manage Cardiology, Thoracic services, Clinical and Diagnostics (theatres, critical care, anaesthesia, radiology and pathology), Transplantation and Surgery on a day-to-day basis. A consultant clinical director and an operational manager lead every directorate with clinical business unit leads for individual services. There are further non-clinical directorates for Research and Development, Human Resources (including Education and Development), and Clinical Governance and Risk Management, together with central General management services. Consultant interventional substantive post Oct 2019 3/13 Papworth hospital has over 1,800 staff excluding contracted-out services. The workforce has grown considerably over the past few years. Modernisation is high on the agenda and there is continual review of networking services, changing working roles and new ways of working. Future Developments Over the last 10 years, we have recorded clinical and financial successes while maintaining and enhancing our excellent relationship with patients and staff. This has been achieved whilst the hospital has steadily grown. The strategic and workforce plans indicate the growth that will be required to achieve the NHS objectives. The hospital’s track record provides a sound base on which to achieve these plans. Key to the success of our future will be continuing workforce expansion and the appointment of high calibre staff to the hospital. The Annual Report 2018 2019 is also on the Royal Papworth Hospital website or follow the link: https://royalpapworth.nhs.uk/our-hospital/information-we-publish/annual-reports Cambridge University Health Partners (CUHP) Royal Papworth Hospital is a founder member of Cambridge University Health Partners, a partnership between one of the world's leading universities and three NHS foundation trusts. It will deliver world-class excellence in health care, research and clinical education and improve health for people across the Cambridgeshire region and beyond. It is a strategic partnership aiming to improve patient care, patient outcomes and population health through innovation and the integration of service delivery, health research and clinical education. http://www.cuhp.org.uk/ 3 The Cardiology Directorate Royal Papworth Hospital is the Regional Cardiothoracic Centre for the East of England with 18 Consultant Cardiologists based at the hospital, plus joint appointments and several visiting Consultants with sessions on site. There are well established and expanding links with Cambridge University Hospitals NHS Foundation Trust (including and the Department of Medicine in the Clinical School and the Department of Biochemistry, University of Cambridge) and our neighbouring District General Hospitals. Cardiology has enjoyed sustained growth with a steady increase in both outpatients and numbers of patients admitted for investigation and treatment. A full range of facilities for non-invasive and invasive investigations is available. These include 6 angiography suites (one of which is a hybrid lab). Other imaging modalities include trans-thoracic, trans-oesophageal,
Load more

Recommended publications
  • ICM Unit Brief
    Unit Brief v1 ICM Unit Brief Part 1 Hospital Details 1.1 Hospital name Royal Papworth Hospital NHS Trust 1.2 Full address (you must include postcode) 1.3 Hospital Telephone number Papworth Road 01223 638000 Cambridge Biomedical Campus Cambridge CB2 0AY Part 2 ICU Department contact details 2.1 Direct telephone number to Department 01223 638180 2.2 Faculty Tutor name 2.3 Faculty Tutor Email address Dr Nicola Jones [email protected] @nhs.net Part 3 Unit Structure 3.1 Number of Beds 3.2 Number of admissions 46 Beds 2000 - 3000 per year 3.3 Percentage of elective vs emergency admissions Approximately 75% of our work is elective and 25% is emergency 3.4 Overview of case mix within the unit Average occupancy by speciality: Cardiac surgery = 50-60% Transplant/heart failure/VADS =15- 20% Respiratory ECMO = 5-10% Pulmonary Thromboendarterectomy = 5-10% 3.Respiratory/thoracic5 Department of = 5 Anaesthesia% and Intensive Care - Names of Consultants, roles and areas of interest Cardiology = 5% Page 1 (of 4) Unit Brief v1 Dr Estefania Arenas MD Cardiothoracic Anaesthesia ALERT Team Lead Dr Joe E Arrowsmith MD FRCP FRCA Cardiothoracic Anaesthesia, GMC Examiner, LNC Chair Dr Angus Butchart FRCA Cardiothoracic Anaesthesia and ICU Dr Christiana Burt MA FRCA LLM Cardiothoracic Anaesthesia ES – Anaesthesia Trainees Dr Thomas Chloros MD Cardiothoracic Anaesthesia and ICU ES – Foundation Doctors Dr Florian Falter MA MD PhD FRCA Cardiothoracic Anaesthesia Department chairman, ES – Anaesthesia Trainees Dr Roger M Hall FANZCA FRCA Cardiothoracic Anaesthesia,
    [Show full text]
  • Abstract Book 2020
    Abstract Book 2020 Contents Page Calne Williams presentations 3 Medawar Medal presentations 7 Oral presentations 15 Posters 51 2 CW1 The relationship between Cardiopulmonary Exercise Testing (CPET) and muscle volume in liver transplant candidates Mr Ben Fox1,2, Mrs Janice Miller2, Dr Helen Usher2, Mr Richard Skipworth2, Professor Stephen Wigmore2 1University of Edinburgh, Edinburgh, United Kingdom. 2Royal Infirmary of Edinburgh, Edinburgh, United Kingdom Introduction: Sarcopenia is described as the progressive and generalised loss of skeletal muscle mass and strength, which often accompanies liver cirrhosis. Cardiopulmonary Exercise Testing (CPET) is a key clinical tool used to assess exercise capacity and is key in predicting surgical outcomes. This study sought to investigate the relationship between CT measures of muscle volume and CPET performance in patients undergoing liver transplant assessment. The secondary aim was to investigate the relationship between sarcopenia and post-operative morbidity and mortality. Methods: A single-centre retrospective cohort study of 400 patients who underwent liver transplant assessment between 1st July 2016 and 1st July 2018 was performed. Routine pre-operative CT scans were used to analyse muscle and adipose tissue which were indexed for height to generate a Skeletal Muscle Index (Cut-off values shown in Table 1). These were compared with CPET variables collected as part of liver transplant assessment work-up. Groups were evaluated using the independent T-test, Chi-squared test and Kaplan-Meier distribution. Results: Of the 400 patients, 54 met the exclusion criteria, leaving 346 for analysis (121 sarcopenic and 225 non- sarcopenic). Clinical significance was found between sarcopenia and Anaerobic Threshold (AT) (p=0.033), Subcostal Girth (p=0.024), predicted Lung Transfer Factor (TCO) (p=0.010), peak Heart Rate (p=0.030), UKELD score (p=0.003) and transplant suitability (p=0.020) (See Figure 1).
    [Show full text]
  • Annual Report and Accounts April 2018 to March 2019
    Annual Report and Accounts April 2018 to March 2019 Royal Papworth Hospital NHS Foundation Trust Annual Report and Accounts April 2018 to March 2019 Presented to Parliament pursuant to Schedule 7, paragraph 25(4) (a) of the National Health Service Act 2006 Royal Papworth Hospital NHS Foundation Trust - Annual Report 2018/19 ©2019 Royal Papworth Hospital NHS Foundation Trust Contents 1 Performance Report 4 1.1 Overview of Performance 4 1.2 Performance Analysis 15 2 Accountability Report 21 2.1 Directors’ Report 21 2.2 Remuneration Report 29 2.3 Staff Report 38 2.4 Disclosures set out in the NHS Foundation Trust Code of Governance 47 2.5 NHS Improvement’s Single Oversight Framework 53 2.6 Board of Directors 54 2.7 Audit Committee 61 2.8 Council of Governors 65 2.9 Foundation Trust Membership 75 2.10 Sustainability 77 2.11 Equality and Diversity Report 79 2.12 Statement of Accounting Officer’s Responsibilities 85 2.13 Annual Governance Statement 87 Quality Report See separate contents page Annual Accounts This report is based on guidelines issued by NHS Improvement and was approved by the Board of Directors on the 23 May 2019. Royal Papworth Hospital NHS Foundation Trust - Annual Report 2018/19 3 1. Performance Report 1.1 Overview of Performance Statement from Chief Executive Officer The last year 2018/19 has been an incredibly important one for Royal Papworth Hospital. In the last year, our staff and partners have worked extremely hard to maintain our excellent quality standards whilst remaining on our Papworth Everard site for an extended period following the delay in the move to our new hospital.
    [Show full text]
  • PI 41 A4 Cardiac Surgery with Consent Form Vs12.1.Indd
    Patient’s guide and agreement to consent form Cardiac surgery Patient’s guide to surgery and enhancing your recovery Agreement to consent form Important Please bring this booklet into hospital on admission 1 This document contains a consent form which your surgeon will go through with you and ask you to sign if you are willing to proceed. You will be given this booklet which will include a copy of the consent form. This information booklet has been prepared to help you and your relatives understand more about your cardiac surgery. It also gives you general information about what to expect from the time of your admission to your discharge from Royal Papworth Hospital, and some practical advice on what to do when you get discharged. Contents Your heart and how it works .............................................................................................................1 Reasons for needing cardiac surgery .................................................................................................1 Aneurysms ...........................................................................................................................................3 What are the risks? .............................................................................................................................3 Live well ...............................................................................................................................................4 Be prepared .........................................................................................................................................5
    [Show full text]
  • Protocol for an Observational Cohort Study and Biobank in Bronchiectasis
    Early View Study protocol BronchUK: Protocol for an observational cohort study and biobank in bronchiectasis Anthony De Soyza, Philip Mawson, Adam T. Hill, Stuart Elborn, Judy M. Bradley, Charles S. Haworth, R. Andres Floto, Robert Wilson, Michael R. Loebinger, Mary Carroll, Megan Crichton, James D. Chalmers, Anita Sullivan, Jeremy Brown, John R. Hurst, Jamie Duckers, Martin Kelly, John Steer, Tim Gatheral, Paul P. Walker, Craig Winstanley, Alistair McGuire, David Denning, Richard McNally Please cite this article as: De Soyza A, Mawson P, Hill AT, et al. BronchUK: Protocol for an observational cohort study and biobank in bronchiectasis. ERJ Open Res 2021; in press (https://doi.org/10.1183/23120541.00775-2020). This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. ©The authors 2021. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact [email protected] BronchUK: Protocol for an observational cohort study and biobank in bronchiectasis. 1 19 2 3 3 4 Anthony De Soyza , Philip Mawson , Adam T. Hill , Stuart Elborn , Judy. M. Bradley , Charles S. Haworth , 4 5 5 6 7 R. Andres Floto , Robert Wilson , Michael. R Loebinger , Mary Carroll , Megan Crichton , James D. 7 8 9 10 11 12 13 Chalmers , Anita Sullivan , Jeremy Brown , John.
    [Show full text]
  • Papworth Hospital NHS Trust
    JOB DESCRIPTION LOCUM CONSULTANT in CARDIOTHORACIC ANAESTHESIA & INTENSIVE CARE Contents Section Page 1 Summary and Key Responsibilities 2 Papworth Hospital NHS Foundation Trust 3 Cardiothoracic Anaesthesia - Staffing, Facilities and Activity 4 Duties of the Post and Proposed Clinical Timetable 5 Research Activities 6 Terms and Conditions 7 Brief Terms of Appointment 8 General Information 9 Informal Visits 10 Person Specification SECTION 1 SUMMARY This post provides anaesthetic support for cardiothoracic surgical and Critical Care services at Papworth Hospital. The post holder will contribute to the provision of anaesthetic services for cardiothoracic surgery, transplant surgery, interventional cardiology, critical care and extra-corporeal membrane oxygenation (ECMO). In addition, the post holder will be required to attend pre-assessment clinics and to participate in early evening elective operating sessions as well as Saturday elective operating sessions. The post includes a commitment to the theatre, critical care and ECMO out of hours rotas on a rotational basis. The post- holder will contribute to the training of medical students, foundation, core and specialist trainees and allied health professionals. In addition the post-holder is expected to initiate and participate in clinical audit, quality improvement and academic activities. The post-holder will be employed full time at Papworth Hospital. KEY RESPONSIBILITIES The day-to-day provision and development of cardiothoracic and transplant anaesthesia, critical care and ECMO at Papworth Hospital. KEY TASKS Shared responsibility with other colleagues for the cardiothoracic anaesthetic service, Critical Care, ECMO and on-call duties as outlined above. Teaching, training and clinical supervision of trainees. Participation in the research, audit and quality improvement activities of the Department of Anaesthesia and Intensive Care.
    [Show full text]
  • Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (From the GLOBAL LEADERS Trial)
    ARTICLE IN PRESS Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial) Chun Chin Chang, MDa,b, Ernest Spitzer, MDa,c, Ply Chichareon, MDd, Kuniaki Takahashi, MDd, Rodrigo Modolo, MDd, Norihiro Kogame, MDd, Mariusz Tomaniak, MDa,e, Hidenori Komiyama, MDd, Sing-Chien Yap, MD, PhDa, Stephen P. Hoole, MDf, Tommaso Gori, MDg, Azfar Zaman, MDh, Bernhard Frey, MDi, Rui Cruz Ferreira, MDj, Olivier F. Bertrand, MD, PhDk, Tian Hai Koh, MDl, Amanda Sousa, MDm, Aris Moschovitis, MDn, Robert-Jan van Geuns, MD, PhDa,o, Philippe Gabriel Steg, MDp, Christian Hamm, MDq,r, Peter Juni,€ DMs,t, Pascal Vranckx, MD, PhDu, Marco Valgimigli, MD, PhDn, Stephan Windecker, MDn, Patrick W. Serruys, MD, PhDv,*, Osama Soliman, MD, PhDa,c, and Yoshinobu Onuma, MD, PhDa,c Q-wave myocardial infarction (QWMI) comprises 2 entities. First, a clinically evident MI, which can occur spontaneously or be related to a coronary procedure. Second, silent MI which is incidentally detected on serial electrocardiographic (ECG) assessment. The preva- lence of silent MI after percutaneous coronary intervention (PCI) in the drug-eluting stent era has not been fully investigated. The GLOBAL LEADERS is an all-comers multicenter trial which randomized 15,991 patients who underwent PCI to 2 antiplatelet treatment strate- gies. The primary end point was a composite of all-cause death or nonfatal new QWMI at 2-years follow-up. ECGs were collected at discharge, 3-month and 2-year visits, and analyzed by an independent ECG core laboratory following the Minnesota code. All new QWMI were further reviewed by a blinded independent cardiologist to identify a potential clinical corre- late by reviewing clinical information.
    [Show full text]
  • Papworth Hospital LOGO
    ‘Measurement of mucus plugging with computer tomography before and following implementation of the AffloVest in adults with bronchiectasis – a feasibility study’ STUDY PROTOCOL – AFFLO Study DATE 09/09/2019 CHIEF INVESTIGATOR Dr Charles Haworth List Investigators Siobhan Singh Andres Floto Nicholas Screaton Timothy Baird Investigation Sites: Royal Papworth Hospital NHS Foundation Trust, Cambridge Biomedical Campus, Papworth Road, Cambridge, CB2 0AY, UK Protocol Identification Number: P02552 Date of Protocol: 09/09/2019 Protocol Version Number: 2 Trial Sponsor: Royal Papworth Hospital NHS Foundation Trust AffloVest Study Proposal version 2 03/09/2019 Page 1 of 13 Contents TRIAL OVERVIEW 1. Trial Overview Primary Research Question Study Design Primary Outcome Secondary Outcome Rationale 2. Patient Recruitment Study Population Inclusion Criteria Exclusion Criteria Recruitment Strategy 3. Data Analysis Sample Size Statistical Analysis 4. Consent Process and Visit Schedule Visit 1 Follow-up Visit Informed Consent Procedure Table 2: Visit Schedule Table 3: Trial Specific Procedures versus Routine Procedures 5. Follow up Visits, Travel Expenses and Other Costs 6. Data Collection, Auditing and Retention of Documents Data Collection Form Completion Source Documentation Errors and Correcting Storage of Documents Retention of Documents Monitoring and Auditing Labelling of Source Documentation 7. Adverse and Serious Adverse Events Recording & Reporting 8. Amendments Amendment log 9. References AffloVest Study Proposal version 2 03/09/2019 Page 2 of 13 TRIAL OVERVIEW 1. Trial Overview Principal Objective: The principal objective is to test the feasibility of using computer tomography and the modified Brody score to measure the amount of mucus plugging within the lungs of adults with bronchiectasis at baseline and after six weeks treatment with the AffloVest.
    [Show full text]
  • British Thoracic Society Guideline for Bronchiectasis in Adults
    BTS Guideline British Thoracic Society Guideline for bronchiectasis Thorax: first published as 10.1136/thoraxjnl-2018-212463 on 13 December 2018. Downloaded from in adults Adam T Hill,1 Anita L Sullivan,2 James D Chalmers,3 Anthony De Soyza,4 J Stuart Elborn,5 R Andres Floto,6,7 Lizzie Grillo,8 Kevin Gruffydd-Jones,9 Alex Harvey,10 Charles S Haworth,7 Edwin Hiscocks,11 John R Hurst,12 Christopher Johnson,7 W Peter Kelleher,13,14,15 Pallavi Bedi,16 Karen Payne,17 Hashem Saleh,8 Nicholas J Screaton,18 Maeve Smith,19 Michael Tunney,20 Deborah Whitters,21 Robert Wilson,14 Michael R Loebinger14 For numbered affiliations see SUMMARY OF RECOMMENDATIONS AND GOOD General end of article. PRACTICE POINTS ✓ CT scanning can also aid in identifying an aeti- How should the diagnosis of bronchiectasis be ology of bronchiectasis eg Allergic bronchopul- Correspondence to Professor Adam T Hill, determined? monary aspergillosis (ABPA), Non-tuberculous Respiratory Medicine, Royal Recommendations – Imaging mycobacteria (NTM), primary ciliary dyski- Infirmary of Edinburgh, ➢ Perform baseline chest X-ray in patients with nesia, alpha one antitrypsin deficiency, Williams Edinburgh and University of suspected bronchiectasis. (D) Campbell syndrome and a foreign body. Edinburgh, EH16 4SA, UK; ➢ adam. hill318@ nhs. net Perform a thin section computed tomography scan (CT) to confirm a diagnosis of bronchiec- In whom should the diagnosis of bronchiectasis tasis when clinically suspected. (C) be suspected? ➢ Perform baseline imaging during clinically Recommendations stable disease as this is optimal for diagnostic ➢ Consider investigation for bronchiectasis in and serial comparison purposes. (D) patients with persistent production of mucop- urulent or purulent sputum particularly with relevant associated risk factors.
    [Show full text]
  • Handbook for Inpatients
    Handbook for inpatients Handbook for inpatients Coming into hospital 1 Handbook for inpatients Welcome Royal Papworth Hospital is a If, while you are in hospital, special place because of the you require any information extraordinary people that not contained in this booklet, work, teach, treat and are please do speak to the nurse in treated every day. charge of the ward or to your doctor, who will be happy to The safety of our patients and help. the experience they have while in our care is very important to If you require additional all staff at Royal Papworth. We information prior to admission, are proud of our reputation please ring the hospital on as the UK’s largest specialist 01480 830541 and ask to speak cardiothoracic hospital, and to the Booking Office or the we achieve some of the best nurse in charge of the ward outcomes in the world for our indicated on your letter. They patients. will be happy to help you. Our patients often travel long With best wishes. distances to see us, confident in the knowledge that we are at the forefront of providing new and innovative treatments Stephen Posey for heart and lung patients. Chief Executive We will do all we can to make you welcome and make your time with us as pleasant and comfortable as possible. This booklet gives you information about preparing for, and being admitted to hospital and what to do when you arrive. It briefly describes the life of the hospital, how your clinical care is provided and also explains arrangements for going home.
    [Show full text]
  • QUACS Quality of Life After Cardiac Surgery a National Multicentre
    QUACS Quality of life after cardiac surgery a national multicentre observational study Protocol Version 3.0 Date 09/09/19 RESEARCH REFERENCE NUMBERS – 19/WA/0123 IRAS Number: 260891 SPONSORS Number: PO2500 i QUACS protocol 3 09/09/19 sSH SIGNATURE PAGE The undersigned confirm that the following protocol has been agreed and accepted and that the Chief Investigator agrees to conduct the study in compliance with the approved protocol and will adhere to the principles outlined in the Declaration of Helsinki, the Sponsor’s SOPs, and other regulatory requirement. I agree to ensure that the confidential information contained in this document will not be used for any other purpose other than the evaluation or conduct of the investigation without the prior written consent of the Sponsor I also confirm that I will make the findings of the study publically available through publication or other dissemination tools without any unnecessary delay and that an honest accurate and transparent account of the study will be given; and that any discrepancies from the study as planned in this protocol will be explained. For and on behalf of the Study Sponsor: Signature: Date: ....../....../...... ...................................................................................................... Name (please print): ...................................................................................................... Position: ...................................................................................................... Chief Investigator: Signature:
    [Show full text]
  • PI 119 Were Here to Help Vs6.Indd
    Information for patients, relatives and carers Patient Advice & Liaison Service (PALS) We’re here to help Information for patients, relatives and carers 1 Information for patients, relatives and carers We’re here to help when you The service aims to: need advice, have concerns, or • Advise and support patients, don’t know where to turn to. their families and carers. • Provide information on NHS As a patient, relative or carer services. sometimes you may need to turn to someone for on-the- • Listen to your concerns, spot help, advice and support. suggestions or queries. • Help sort out problems This is where the Patient Advice quickly on your behalf. and Liaison Service (PALS) comes in. We act independently when handling patient and We provide confidential advice family concerns, liaising and support, helping you to with staff, managers and, sort out any concerns you where appropriate, relevant may have about the care we organisations, to negotiate provide, guiding you through immediate or prompt solutions. the different services available from the NHS. If necessary, we can also refer patients and families to specific The Patient Advice and Liaison local or national-based support Service focuses on improving agencies. the service to NHS patients. The aim of the service is to make a genuine difference to the overall quality of health services provided and accessed by local people. 1 Information for patients, relatives and carers The service is confidential and can be contacted via: PALS Supervisor Royal Papworth Hospital NHS Foundation Trust
    [Show full text]